Planning Grant for Institutional Clinical and Translational Science Award

机构临床和转化科学奖规划拨款

• 批准号: 7216103
• 负责人: Thomas A Buchanan
• 金额: $ 24.45万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-24 至 2007-09-23
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7216103
• 关键词: NIH Roadmap Initiative tag; clinical research; education evaluation /planning; health science research; health science research support; interdisciplinary collaboration; science education; training

DESCRIPTION (provided by applicant): We propose to develop a plan for the content, governance, administration and evaluation of an Institutional Clinical and Translational Science Award in an Institute or Center of Clinical and Translational Sciences at the University of Southern California (USC) and two participating institutions, Children's Hospital Los Angeles (CHLA), and the City of Hope (COH) Medical Center. These institutions have a broad range of high-quality basic, translational, clinical and community research and training programs that, at present, are not integrated or coordinated to conduct efficient and effective bench to bedside or bedside to community research. A formal strategic planning process is underway in consultation with an academic consultant, AMC Strategies: (a) Phase I: Preliminary Research is nearly completed and will provide, through faculty members interviews, a retreat and an environmental assessment, a base of qualitative and quantitative information from which we can develop specific goals, strategies and tactics for development of a CTSA application, (b)Phase II: Global Directions - will result in a vision statement and clear and measurable goals for a CTSA application, (c) Phase III: Development of Strategies and Tactics - will be overseen by a Steering Committee, working with AMC Strategies, and conducted by four design teams structured to address major functional components of a CTSA. The design teams will make formal strategic and tactical recommendations, (d) Phase IV: Final Strategic Plan: The Design Team and AMC Strategies will create the final strategic plan, identify the resources that will be required to implement it, develop a detailed implementation plan, and communicate the plan to the key constituencies across the participating institutions, (e) Grant Writing: Based on the strategic plan and resource requirement, the Principal Investigator, Co-Is and Steering Committee will prepare an application to NIH for a CTSA (anticipated early 2007). This planning process has broad support among the leadership and faculty members of the participating institutions and promises to create a robust plan for an academic home for clinical and translational science at USC, CHLA and COH Medical Center.

描述（由申请人提供）：我们建议制定一项计划，用于南加州大学（USC）临床和转化科学研究所或中心以及两个参与机构（洛杉矶儿童医院（CHLA）和City of Hope（COH）医学中心）的机构临床和转化科学奖的内容、治理、管理和评估。这些机构拥有广泛的高质量基础，转化，临床和社区研究和培训计划，目前尚未整合或协调，以进行有效和有效的实验室到床边或床边社区研究。一个正式的战略规划过程正在与学术顾问咨询，AMC战略：（a）第一阶段：初步研究即将完成，并将提供，通过教师访谈，务虚会和环境评估，定性和定量信息的基础，我们可以制定具体的目标，战略和战术的CTSA应用程序的发展，（B）第二阶段：全球方向-将为CTSA应用程序制定愿景声明和明确且可衡量的目标，（c）第三阶段：战略和战术的制定-将由指导委员会监督，与AMC战略合作，并由四个设计团队进行，以解决CTSA的主要功能组件。设计团队将提出正式的战略和战术建议，（d）第四阶段：最终战略计划：设计团队和AMC战略将制定最终战略计划，确定实施该计划所需的资源，制定详细的实施计划，并将计划传达给参与机构的主要支持者，（e）拨款写作：根据战略计划和资源要求，主要研究者、Co-Is和指导委员会将准备向NIH申请CTSA（预计2007年初）。这一规划过程得到了参与机构领导层和教职员工的广泛支持，并有望为南加州大学、CHLA和COH医疗中心的临床和转化科学学术之家制定一个强有力的计划。